Mylan, Takeda Bury Hatchet In Diabetes Drug Feud
Mylan Inc. has resolved two patent infringement suits brought by Takeda Pharmaceutical Co. Ltd. over plans to market generic versions of diabetes drugs Actos and Actoplus Met....To view the full article, register now.
Already a subscriber? Click here to view full article